Effect of immediate initiation of antiretroviral treatment in HIV-positive individuals aged 50 years or older
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/25424 |
Resumo: | 2018-12-31 |
id |
CRUZ_292477156522728a6c55bcdda1d467cc |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/25424 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Lodi, SaraCostagliola, DominiqueSabin, CarolineDel Amo, JuliaLogan, RogerAbgrall, SophieReiss, Petervan Sighem, ArdJose, SophieBlanco, Jose-RamonHernando, VictoriaBucher, Heiner C.Kovari, HelenSegura, FerranAmbrosioni, JuanGogos, Charalambos A.Pantazis, NikosDabis, FrancoisVandenhende, Marie-AnneMeyer, LaurenceSeng, RémonieGill, M JohnKrentz, HartmutPhillips, Andrew N.Porter, KholoudGrinsztejn, BeatrizPacheco, Antonio G.Muga, RobertoTate, JanetJustice, AmyHernán, Miguel A.2018-03-20T15:09:24Z2018-03-20T15:09:24Z2017LODI, Sara et al. Effect of immediate initiation of antiretroviral treatment in HIV-positive individuals aged 50 years or older. JAIDS Journal of Acquired Immune Deficiency Syndromes. v. 76, n. 3, p. 311-318, Nov. 2017.1525-4135https://www.arca.fiocruz.br/handle/icict/2542410.1097/QAI.0000000000001498porEnvelhecimentoContagem de linfócito CD4AgingAntiretroviral treatmentCD4 Lymphocyte CountCausal inferenceComparative Effectiveness ResearchAntiretroviralsCD4 Lymphocyte CountComparative Effectiveness ResearchAgingEffect of immediate initiation of antiretroviral treatment in HIV-positive individuals aged 50 years or olderinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article2018-12-31Harvard T.H. Chan School of Public Health. Department of Epidemiology. Boston.Institut Pierre Louis d’épidémiologie et de Santé Publique. Sorbonne Universités, INSERM, UPMC Univ Paris 06. France.Institute of Global Health.University College London. London, United Kingdom.Instituto de Salud Carlos III. Centro Nacional de Epidemiologia. Madrid, Spain / Instituto de Salud Carlos III. CIBERESP. Madrid, Spain.Harvard T.H. Chan School of Public Health. Department of Epidemiology. Boston.Institut Pierre Louis d’épidémiologie et de Santé Publique. Sorbonne Universités, INSERM, UPMC Univ. Paris. Paris, France / Hôpital Antoine Béclère, Service de Médecine Interne. AP-HP, Clamart, France.Stichting HIV Monitoring. Amsterdam, the Netherlands / Academic Medical Centre, Department of Global Health and Division of Infectious Diseases, University of Amsterdam, Amsterdam, the Netherlands / Amsterdam Institute for Global Health and Development, Amsterdam, the Netherlands.Stichting HIV Monitoring. Amsterdam, the Netherlands.Institute of Global Health.University College London. London, United Kingdom.Hospital San Pedro—CIBIR, Logroño, Spain.Instituto de Salud Carlos III. Centro Nacional de Epidemiologia. Madrid, Spain / Instituto de Salud Carlos III. CIBERESP. Madrid, Spain.University of Basel. University Hospital Basel. Basel Institute for Clinical Epidemiology and Biostatistics, Basel, Switzerland.University of Zurich. University Hospital Zurich. Division of Infectious Diseases and Hospital Epidemiology. Zurich, Switzerland.Hospital Parc Tauli. Infectious Disease Department. Sabadell, Spain.Hospital Clinic-IDIBAPS. Barcelona, Spain.Patras University Hospital. Division of Infectious Diseases. Patras, Greece.National and Kapodistrian University of Athens. Faculty of Medicine. Department of Hygiene, Epidemiology and Medical Statistics. Athens, Greece.Université de Bordeaux, ISPED, Centre INSERM U1219-Epidemiologie-Biostatistique, Bordeaux, France / Université de Bordeaux. Centre INSERM U1219- Centre Inserm Epidémiologie et Biostatistique, Bordeaux, France.Université de Bordeaux, ISPED, Centre INSERM U1219-Epidemiologie-Biostatistique, Bordeaux, France. / Université de Bordeaux. Centre INSERM U1219- Centre Inserm Epidémiologie et Biostatistique, Bordeaux, France / Bordeaux University Hospital. Department of Internal Medicine, Bordeaux, France.Université Paris Sud, UMR 1018, le Kremlin Bicêtre, Paris, France / Inserm, UMR 1018, le Kremlin Bicêtre, Paris, France / AP-HP, Hôpital de Bicêtre, Service de Santé Publique, le Kremlin Bicêtre, Paris, France.Inserm, UMR 1018, le Kremlin Bicêtre, Paris, France / AP-HP, Hôpital de Bicêtre, Service de Santé Publique, le Kremlin Bicêtre, Paris, France.Southern Alberta Clinic, Calgary, AB, Canada / Department of Medicine, University of Calgary, Calgary, AB, Canada.Southern Alberta Clinic, Calgary, AB, Canada / Department of Medicine, University of Calgary, Calgary, AB, Canada.Instituto de Salud Carlos III. Centro Nacional de Epidemiologia. Madrid, Spain.Instituto de Salud Carlos III. Centro Nacional de Epidemiologia. Madrid, Spain.Fundacao Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brasil.Fundacao Oswaldo Cruz. Programa de Computação Científica, Rio de Janeiro, Brasil.Hospital Universitari Germans Trias i Pujol, Badalona, Spain.Yale University School of Medicine. Department of Internal Medicine, New Haven.Yale University School of Medicine. Department of Internal Medicine, New Haven / VA Connecticut Healthcare System, West Haven, CT.Harvard T.H. Chan School of Public Health. Department of Epidemiology. Boston / Harvard T.H. Chan School of Public Health. Department of Biostatistics, Boston / Harvard-MIT Division of Health Sciences and Technology, Boston, MA.Clinical guidelines recommend immediate initiation of combined antiretroviral therapy for all HIV-positive individuals. However, those guidelines are based on trials of relatively young participants.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-83099https://www.arca.fiocruz.br/bitstream/icict/25424/1/license.txt586c046dcfeef936e32f0323bb9a47c0MD51ORIGINALEffect of immediate initiation of antiretroviral treatment in HIV-positive individuals aged 50 years or older.pdfEffect of immediate initiation of antiretroviral treatment in HIV-positive individuals aged 50 years or older.pdfapplication/pdf2183723https://www.arca.fiocruz.br/bitstream/icict/25424/2/Effect%20of%20immediate%20initiation%20of%20antiretroviral%20treatment%20in%20HIV-positive%20individuals%20aged%2050%20years%20or%20older.pdfccb422bcccab25adadd98d7f47e99144MD52TEXTEffect of immediate initiation of antiretroviral treatment in HIV-positive individuals aged 50 years or older.pdf.txtEffect of immediate initiation of antiretroviral treatment in HIV-positive individuals aged 50 years or older.pdf.txtExtracted texttext/plain40918https://www.arca.fiocruz.br/bitstream/icict/25424/3/Effect%20of%20immediate%20initiation%20of%20antiretroviral%20treatment%20in%20HIV-positive%20individuals%20aged%2050%20years%20or%20older.pdf.txtd75bb737e36aa82b10abd15e77a73279MD53icict/254242021-02-10 19:38:06.142oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352021-02-10T22:38:06Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.pt_BR.fl_str_mv |
Effect of immediate initiation of antiretroviral treatment in HIV-positive individuals aged 50 years or older |
title |
Effect of immediate initiation of antiretroviral treatment in HIV-positive individuals aged 50 years or older |
spellingShingle |
Effect of immediate initiation of antiretroviral treatment in HIV-positive individuals aged 50 years or older Lodi, Sara Envelhecimento Contagem de linfócito CD4 Aging Antiretroviral treatment CD4 Lymphocyte Count Causal inference Comparative Effectiveness Research Antiretrovirals CD4 Lymphocyte Count Comparative Effectiveness Research Aging |
title_short |
Effect of immediate initiation of antiretroviral treatment in HIV-positive individuals aged 50 years or older |
title_full |
Effect of immediate initiation of antiretroviral treatment in HIV-positive individuals aged 50 years or older |
title_fullStr |
Effect of immediate initiation of antiretroviral treatment in HIV-positive individuals aged 50 years or older |
title_full_unstemmed |
Effect of immediate initiation of antiretroviral treatment in HIV-positive individuals aged 50 years or older |
title_sort |
Effect of immediate initiation of antiretroviral treatment in HIV-positive individuals aged 50 years or older |
author |
Lodi, Sara |
author_facet |
Lodi, Sara Costagliola, Dominique Sabin, Caroline Del Amo, Julia Logan, Roger Abgrall, Sophie Reiss, Peter van Sighem, Ard Jose, Sophie Blanco, Jose-Ramon Hernando, Victoria Bucher, Heiner C. Kovari, Helen Segura, Ferran Ambrosioni, Juan Gogos, Charalambos A. Pantazis, Nikos Dabis, Francois Vandenhende, Marie-Anne Meyer, Laurence Seng, Rémonie Gill, M John Krentz, Hartmut Phillips, Andrew N. Porter, Kholoud Grinsztejn, Beatriz Pacheco, Antonio G. Muga, Roberto Tate, Janet Justice, Amy Hernán, Miguel A. |
author_role |
author |
author2 |
Costagliola, Dominique Sabin, Caroline Del Amo, Julia Logan, Roger Abgrall, Sophie Reiss, Peter van Sighem, Ard Jose, Sophie Blanco, Jose-Ramon Hernando, Victoria Bucher, Heiner C. Kovari, Helen Segura, Ferran Ambrosioni, Juan Gogos, Charalambos A. Pantazis, Nikos Dabis, Francois Vandenhende, Marie-Anne Meyer, Laurence Seng, Rémonie Gill, M John Krentz, Hartmut Phillips, Andrew N. Porter, Kholoud Grinsztejn, Beatriz Pacheco, Antonio G. Muga, Roberto Tate, Janet Justice, Amy Hernán, Miguel A. |
author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Lodi, Sara Costagliola, Dominique Sabin, Caroline Del Amo, Julia Logan, Roger Abgrall, Sophie Reiss, Peter van Sighem, Ard Jose, Sophie Blanco, Jose-Ramon Hernando, Victoria Bucher, Heiner C. Kovari, Helen Segura, Ferran Ambrosioni, Juan Gogos, Charalambos A. Pantazis, Nikos Dabis, Francois Vandenhende, Marie-Anne Meyer, Laurence Seng, Rémonie Gill, M John Krentz, Hartmut Phillips, Andrew N. Porter, Kholoud Grinsztejn, Beatriz Pacheco, Antonio G. Muga, Roberto Tate, Janet Justice, Amy Hernán, Miguel A. |
dc.subject.other.pt_BR.fl_str_mv |
Envelhecimento Contagem de linfócito CD4 |
topic |
Envelhecimento Contagem de linfócito CD4 Aging Antiretroviral treatment CD4 Lymphocyte Count Causal inference Comparative Effectiveness Research Antiretrovirals CD4 Lymphocyte Count Comparative Effectiveness Research Aging |
dc.subject.en.pt_BR.fl_str_mv |
Aging Antiretroviral treatment CD4 Lymphocyte Count Causal inference Comparative Effectiveness Research |
dc.subject.decs.pt_BR.fl_str_mv |
Antiretrovirals CD4 Lymphocyte Count Comparative Effectiveness Research Aging |
description |
2018-12-31 |
publishDate |
2017 |
dc.date.issued.fl_str_mv |
2017 |
dc.date.accessioned.fl_str_mv |
2018-03-20T15:09:24Z |
dc.date.available.fl_str_mv |
2018-03-20T15:09:24Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
LODI, Sara et al. Effect of immediate initiation of antiretroviral treatment in HIV-positive individuals aged 50 years or older. JAIDS Journal of Acquired Immune Deficiency Syndromes. v. 76, n. 3, p. 311-318, Nov. 2017. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/25424 |
dc.identifier.issn.pt_BR.fl_str_mv |
1525-4135 |
dc.identifier.doi.none.fl_str_mv |
10.1097/QAI.0000000000001498 |
identifier_str_mv |
LODI, Sara et al. Effect of immediate initiation of antiretroviral treatment in HIV-positive individuals aged 50 years or older. JAIDS Journal of Acquired Immune Deficiency Syndromes. v. 76, n. 3, p. 311-318, Nov. 2017. 1525-4135 10.1097/QAI.0000000000001498 |
url |
https://www.arca.fiocruz.br/handle/icict/25424 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/25424/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/25424/2/Effect%20of%20immediate%20initiation%20of%20antiretroviral%20treatment%20in%20HIV-positive%20individuals%20aged%2050%20years%20or%20older.pdf https://www.arca.fiocruz.br/bitstream/icict/25424/3/Effect%20of%20immediate%20initiation%20of%20antiretroviral%20treatment%20in%20HIV-positive%20individuals%20aged%2050%20years%20or%20older.pdf.txt |
bitstream.checksum.fl_str_mv |
586c046dcfeef936e32f0323bb9a47c0 ccb422bcccab25adadd98d7f47e99144 d75bb737e36aa82b10abd15e77a73279 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1813008858868613120 |